Protalix BioTherapeutics Inc. (PLX)

May 17, 2025

What is Zacks Small Cap’s Estimate for PLX Q2 Earnings? - Defense World

May 17, 2025

May 14, 2025

Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainw - GuruFocus

May 14, 2025

May 14, 2025

Protalix BioTherapeutics CFO to Present Latest Biotech Innovations at Exclusive Nasdaq Conference - Stock Titan

May 14, 2025

May 13, 2025

PLX: First Quarter Results - MSN

May 13, 2025

May 13, 2025

Protalix BioTherapeutics (NYSE:PLX) Lowered to Buy Rating by StockNews.com - Defense World

May 13, 2025

May 12, 2025

Protalix BioTherapeutics targets phase 2 launch for PRX-115 in H2 2025 - MSN

May 12, 2025

May 10, 2025

Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025

May 10, 2025

Protalix: Q1 Earnings Snapshot - New Haven Register

May 10, 2025

May 10, 2025

Protalix BioTherapeutics Inc (PLX) Q1 2025 Earnings Call Highlights: Revenue Surge and ... - Yahoo Finance

May 10, 2025

May 10, 2025

Protalix BioTherapeutics Inc (PLX) Q1 2025 Earnings Call Highlig - GuruFocus

May 10, 2025

May 10, 2025

Protalix BioTherapeutics Inc (PLX) Q1 2025 Earnings Call Highlights: Revenue Surge and ... By GuruFocus - Investing.com Canada

May 10, 2025

May 10, 2025

Earnings call transcript: Protalix Q1 2025 results miss forecasts, stock plunges - Investing.com

May 10, 2025

May 10, 2025

Protalix BioTherapeutics Reports Strong Q1 2025 Growth - TipRanks

May 10, 2025

May 09, 2025

Protalix BioTherapeutics (PLX) Sees Revenue Surge Amid Pipeline Advancements - GuruFocus

May 09, 2025

May 09, 2025

Small cap wrap: Protalix Biotherapeutics, Delivra Health, HIVE Digital, U.S. Global Investors... - Proactive financial news

May 09, 2025

May 09, 2025

Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 09, 2025

May 09, 2025

Protalix eyes Phase II gout trial later this year following solid Q1 revenue growth - Proactive financial news

May 09, 2025

May 09, 2025

Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results | PLX Stock News - GuruFocus

May 09, 2025

May 09, 2025

Protalix BioTherapeutics Inc Reports Q1 2025 Earnings: Revenue at $10.1M, Missing Estimates; EPS at -$0.05, Below Expectations - GuruFocus

May 09, 2025

May 09, 2025

Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results - PR Newswire

May 09, 2025

May 07, 2025

Market Insight: Protalix BioTherapeutics Inc (PLX)’s Notable Drop, Closing at 2.73 - DWinneX

May 07, 2025

May 05, 2025

Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025 - The Malaysian Reserve

May 05, 2025

May 05, 2025

Protalix BioTherapeutics to Announce First Quarter 2025 Financia - GuruFocus

May 05, 2025

May 05, 2025

Protalix Earnings: Biotech Pioneer to Present Q1 2025 Results and Pipeline Updates May 9 - Stock Titan

May 05, 2025

May 03, 2025

Contrasting Genocea Biosciences (NASDAQ:GNCA) & Protalix BioTherapeutics (NYSE:PLX) - Defense World

May 03, 2025

May 02, 2025

Can you still get a good price for Protalix BioTherapeutics Inc (PLX) Shares at this point? - uspostnews.com

May 02, 2025

May 02, 2025

Fabry Disease Treatment Market Deep Research 2025-2032 | Idorsia Pharmaceuticals Ltd., Protalix BioTherapeutics - openPR.com

May 02, 2025

May 02, 2025

HC Wainwright Has Bullish Forecast for PLX Q1 Earnings - Defense World

May 02, 2025

May 01, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: Protalix BioTherapeutics Inc (PLX) - Sete News

May 01, 2025

Apr 30, 2025

Protalix stock soars to 52-week high, hits $3.04 - Investing.com

Apr 30, 2025

Apr 30, 2025

Protalix stock soars to 52-week high, hits $3.04 By Investing.com - Investing.com India

Apr 30, 2025

Apr 30, 2025

Monitoring Protalix BioTherapeutics Inc (PLX) after recent insider movements - knoxdaily.com

Apr 30, 2025

Apr 29, 2025

Protalix BioTherapeutics (PLX) Plans $100 Million Securities Off - GuruFocus

Apr 29, 2025

Apr 29, 2025

Fabry Disease Market: Epidemiology, Drugs, Companies, DelveInsight | Amicus Therapeutics, CHIESI Farmaceutici and Protalix Biotherapeutics, Sanofi (Genzyme), Takeda Pharmaceuticals, Sangamo Therapeuti - The Globe and Mail

Apr 29, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 24, 2025

PLX’s earnings estimates: Are they on track to meet expectations? - uspostnews.com

Apr 24, 2025

Apr 24, 2025

Protalix BioTherapeutics Inc Inc. (PLX) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 24, 2025

Apr 24, 2025

Protalix CFO Eyal Rubin to resign in six months By Investing.com - Investing.com India

Apr 24, 2025

Apr 23, 2025

Protalix BioTherapeutics' CFO Rubin to Leave - MarketWatch

Apr 23, 2025

Apr 23, 2025

Protalix stock soars to 52-week high, hits $2.76 By Investing.com - Investing.com South Africa

Apr 23, 2025

Apr 23, 2025

Eyal Rubin Resigns As CFO Of Protalix BiotherapeuticsSEC Filing - marketscreener.com

Apr 23, 2025

Apr 23, 2025

Protalix CFO Eyal Rubin to resign in six months - Investing.com

Apr 23, 2025

Apr 23, 2025

Protalix stock soars to 52-week high, hits $2.76 - Investing.com

Apr 23, 2025

Apr 23, 2025

The growth track for Protalix BioTherapeutics Inc (PLX) has changed recently - Sete News

Apr 23, 2025